Decrease in the incidence of meticillin-resistant Staphylococcus aureus nosocomial bloodstream infections in Taiwan

[1]  E. Lingaas,et al.  Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Kiran Shekar,et al.  ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO , 2012, BMC Anesthesiology.

[3]  A. Friedrich,et al.  Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. , 2012, International journal of antimicrobial agents.

[4]  J. Xing,et al.  Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients. , 2011, International journal of antimicrobial agents.

[5]  P. Viale,et al.  Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis , 2010, Antimicrobial Agents and Chemotherapy.

[6]  Y. Chuang,et al.  Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981–2007 , 2010, Journal of Hospital Infection.

[7]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[8]  T. Rimmele,et al.  Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia* , 2005, Critical care medicine.

[9]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .